Xuekai Wang

534 total citations · 1 hit paper
17 papers, 388 citations indexed

About

Xuekai Wang is a scholar working on Epidemiology, Molecular Biology and Immunology. According to data from OpenAlex, Xuekai Wang has authored 17 papers receiving a total of 388 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 4 papers in Molecular Biology and 4 papers in Immunology. Recurrent topics in Xuekai Wang's work include Liver Disease Diagnosis and Treatment (6 papers), Berberine and alkaloids research (2 papers) and Liver physiology and pathology (2 papers). Xuekai Wang is often cited by papers focused on Liver Disease Diagnosis and Treatment (6 papers), Berberine and alkaloids research (2 papers) and Liver physiology and pathology (2 papers). Xuekai Wang collaborates with scholars based in China. Xuekai Wang's co-authors include Zong‐Gen Peng, Huaying Fan, Kai Ji, Qi Dong, Jianrui Li, Biao Dong, Lei Lei, Jing Jiang, Mingyan Yang and Hongying Li and has published in prestigious journals such as International Journal of Molecular Sciences, Journal of Ethnopharmacology and European Journal of Pharmacology.

In The Last Decade

Xuekai Wang

15 papers receiving 387 citations

Hit Papers

Bacteroides thetaiotaomic... 2024 2026 2024 10 20 30 40 50
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Bacteroides thetaiotaomicron ameliorates mouse hepatic steatosis through regulating gut microbial composition, gut-liver folate and unsaturated fatty acids metabolism
    2024 56 citations Hu Li, Xuekai Wang et al. Gut Microbes profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Xuekai Wang 170 90 62 54 43 17 388
Nagaraj M. Kulkarni 151 0.9× 86 1.0× 32 0.5× 57 1.1× 47 1.1× 19 410
Xianan Sang 294 1.7× 95 1.1× 63 1.0× 43 0.8× 53 1.2× 34 551
Shu Dai 193 1.1× 86 1.0× 66 1.1× 47 0.9× 31 0.7× 24 452
Haojie Du 184 1.1× 74 0.8× 48 0.8× 71 1.3× 38 0.9× 19 446
Kwang-Youn Kim 231 1.4× 81 0.9× 77 1.2× 37 0.7× 32 0.7× 42 475
Linan Zhao 201 1.2× 44 0.5× 49 0.8× 57 1.1× 32 0.7× 25 495
Ling Huang 184 1.1× 54 0.6× 86 1.4× 32 0.6× 24 0.6× 49 473
Hyeon‐Hui Ki 143 0.8× 78 0.9× 52 0.8× 45 0.8× 37 0.9× 17 348
Xiangwei Xu 245 1.4× 94 1.0× 31 0.5× 42 0.8× 45 1.0× 41 482

Countries citing papers authored by Xuekai Wang

Since Specialization
Citations

This map shows the geographic impact of Xuekai Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuekai Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuekai Wang more than expected).

Fields of papers citing papers by Xuekai Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuekai Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuekai Wang. The network helps show where Xuekai Wang may publish in the future.

Co-authorship network of co-authors of Xuekai Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Xuekai Wang. A scholar is included among the top collaborators of Xuekai Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuekai Wang. Xuekai Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Lei, Lei, Hu Li, Xuekai Wang, et al.. (2025). Tubulointerstitial nephritis antigen-like 1 promotes the progression of liver fibrosis after HCV eradication with direct-acting antivirals. International Journal of Biological Sciences. 21(2). 802–822.
2.
3.
Jiang, Jing, Hu Li, Hu Li, et al.. (2024). Upregulation of Hepatic Glutathione S-Transferase Alpha 1 Ameliorates Metabolic Dysfunction-Associated Steatosis by Degrading Fatty Acid Binding Protein 1. International Journal of Molecular Sciences. 25(10). 5086–5086. 4 indexed citations
4.
5.
Zhang, Yanyan, et al.. (2024). Taohong siwu decoction ameliorates abnormal uterine bleeding via inhibiting ACSL4-mediated ferroptosis. Journal of Ethnopharmacology. 339. 119130–119130. 2 indexed citations
6.
Li, Hu, Xuekai Wang, Mei Tang, et al.. (2024). Bacteroides thetaiotaomicron ameliorates mouse hepatic steatosis through regulating gut microbial composition, gut-liver folate and unsaturated fatty acids metabolism. Gut Microbes. 16(1). 2304159–2304159. 56 indexed citations breakdown →
7.
Song, Nannan, Siqi Zhang, Xuekai Wang, et al.. (2023). Discovery of a pyrrole-pyridinimidazole derivative as novel SIRT6 inhibitor for sensitizing pancreatic cancer to gemcitabine. Cell Death and Disease. 14(8). 499–499. 18 indexed citations
8.
Wang, Xuekai, Jianrui Li, Mei Tang, et al.. (2023). Establishment and application of a high-throughput screening model for cell adhesion inhibitors. Frontiers in Pharmacology. 14. 1140163–1140163. 3 indexed citations
9.
Li, Hu, Nannan Liu, Jianrui Li, et al.. (2022). Combined Use of Bicyclol and Berberine Alleviates Mouse Nonalcoholic Fatty Liver Disease. Frontiers in Pharmacology. 13. 843872–843872. 16 indexed citations
10.
Wang, Meixi, Jianrui Li, Hu Li, et al.. (2022). Down-Regulating the High Level of 17-Beta-Hydroxysteroid Dehydrogenase 13 Plays a Therapeutic Role for Non-Alcoholic Fatty Liver Disease. International Journal of Molecular Sciences. 23(10). 5544–5544. 23 indexed citations
11.
Wang, Xuekai & Zong‐Gen Peng. (2021). Targeting Liver Sinusoidal Endothelial Cells: An Attractive Therapeutic Strategy to Control Inflammation in Nonalcoholic Fatty Liver Disease. Frontiers in Pharmacology. 12. 655557–655557. 32 indexed citations
12.
Wang, Xuekai, Qi Dong, Fenghua Fu, et al.. (2019). Therapeutic and antiproteinuric effects of salvianolic acid A in combined with low-dose prednisone in minimal change disease rats: Involvement of PPARγ/Angptl4 and Nrf2/HO-1 pathways. European Journal of Pharmacology. 858. 172342–172342. 18 indexed citations
13.
14.
Yu, Chen, Xuekai Wang, Xin Li, et al.. (2019). Quercetin reduces TNF‐α‐induced mesangial cell proliferation and inhibits PTX3 production: Involvement of NF‐κB signaling pathway. Phytotherapy Research. 33(9). 2401–2408. 26 indexed citations
15.
Yu, Cuicui, Xuekai Wang, Xin Li, et al.. (2018). Andrographolide derivative CX-10 ameliorates dextran sulphate sodium-induced ulcerative colitis in mice: Involvement of NF-κB and MAPK signalling pathways. International Immunopharmacology. 57. 82–90. 68 indexed citations
16.
Dong, Qi, Xuekai Wang, Li Peng, et al.. (2017). Protective effect of Salvianolic acid A on ischaemia‐reperfusion acute kidney injury in rats through protecting against peritubular capillary endothelium damages. Phytotherapy Research. 32(1). 103–114. 21 indexed citations
17.
Wang, Xuekai, et al.. (2010). Label-free Colorimetric Assay Based on Gold Nanoparticles in Detection of NOS1AP with Single Nucleotide Polymorphism. Gaodeng xuexiao huaxue xuebao. 31(10). 1965. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nagaraj M. Kulkarni Breakdown of academic impact, for papers by Xianan Sang Breakdown of academic impact, for papers by Shu Dai Breakdown of academic impact, for papers by Haojie Du Breakdown of academic impact, for papers by Kwang-Youn Kim Breakdown of academic impact, for papers by Linan Zhao Breakdown of academic impact, for papers by Ling Huang Breakdown of academic impact, for papers by Hyeon‐Hui Ki Breakdown of academic impact, for papers by Xiangwei Xu
Rankless by CCL
2026